币界网报道：Microsoft's MAI-DxO AI diagnostic system has achieved an 85.5% accuracy rate in clinical trials, marking a significant advancement in AI-powered healthcare solutions. The system, developed by Microsoft's AI research division, analyzes medical imaging data to assist doctors in diagnosing diseases more efficiently. During testing, MAI-DxO demonstrated particularly strong performance in detecting early-stage conditions, reducing diagnostic errors by approximately 30% compared to traditional methods. Microsoft plans to integrate this technology into its Azure cloud platform, making it available to healthcare providers globally. The company is currently working with regulatory bodies to obtain necessary approvals for clinical deployment. This development comes as part of Microsoft's broader $20 billion investment in AI healthcare